SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : JDS Uniphase (JDSU) -- Ignore unavailable to you. Want to Upgrade?


To: SJS who wrote (13233)10/24/2000 2:55:02 PM
From: William F. Wager, Jr.  Respond to of 24042
 
SDL Inc Gets FDA Warning On Laser System Problems

Dow Jones Newswires

WASHINGTON -- SDL Inc. (SDLI) received a warning letter from the Food and Drug
Administration for an alleged problem with the company's Diode Laser System used to treat
eye defects.

According to Federal Filings Business News, a letter to the company from the agency said
FDA inspectors found a key from the FD-25 model of the laser could be removed when it was
in the "on" position.

Upon further investigation, the letter said, 40 FD-25 models, 289 FL-10 models and four FL-20
models were shipped despite having the problem.

FDA investigators also cited poor record-keeping on testing of the laser systems. "When you
have completed any production changes necessary to assure compliance of future units and
you have submitted the required reports and report supplements, you may resume
introduction of these products...," the letter stated.

According to the company's Web site, SDL products are used in the treatment of eye-related
cases such as photo-coagulation in the treatment of diabetic retinopathy. The company also
offers optical pumps for Diode Pumped Solid State Lasers (DPSSL) and micro-lasers used
for surgical and cosmetic practices.

As reported July 10, JDS Uniphase Corp. (JDSU) and SDL Inc. announced a merger
agreement, where each share of SDL will be exchanged for 3.8 shares of JDS Uniphase.

Shares of SDL Inc. were recently trading at $317.56, down $14.56, or 4.5%. Nasdaq volume
reached 3,760,200 shares, compared to a daily average of 4,514,423.